In vivo synergistic tumor therapies based on copper sulfide photothermal therapeutic nanoplatforms
Jingwen Ma,
Na Li,
Jingjian Wang,
Zhe Liu,
Yulong Han,
Yun Zeng
Affiliations
Jingwen Ma
Radiology Department CT and MRI Room Ninth Hospital of Xi'an Ninth Affiliated Hospital of Medical College of Xi'an Jiaotong University Xi'anShaanxi ProvinceP. R. China
Na Li
Radiology Department CT and MRI Room Ninth Hospital of Xi'an Ninth Affiliated Hospital of Medical College of Xi'an Jiaotong University Xi'anShaanxi ProvinceP. R. China
Jingjian Wang
Radiology Department CT and MRI Room Ninth Hospital of Xi'an Ninth Affiliated Hospital of Medical College of Xi'an Jiaotong University Xi'anShaanxi ProvinceP. R. China
Zhe Liu
Department of Pathology Ninth Hospital of Xi'an Ninth Affiliated Hospital of Medical College of Xi'an Jiaotong University Xi'anShaanxi ProvinceP. R. China
Yulong Han
School of Engineering and Applied Sciences Harvard University CambridgeMassachusettsUSA
Yun Zeng
School of Life Science and Technology Xidian University and Engineering Research Center of Molecular and Neuro Imaging, Ministry of Education Xi'anShaanxi ProvinceP. R. China
Abstract Tumor cells may be eliminated by increasing their temperature. This is achieved via photothermal therapy (PTT) by penetrating the tumor tissue with near‐infrared light and converting light energy into heat using photothermal agents. Copper sulfide nanoparticles (CuS NPs) are commonly used as PTAs in PTT. In this review, we aimed to discuss the synergism between tumor PTT with CuS NPs and other therapies such as chemotherapy, radiotherapy, dynamic therapies (photodynamic, chemodynamic, and sonodynamic therapy), immunotherapy, gene therapy, gas therapy, and magnetic hyperthermia. Furthermore, we summarized the results obtained with a combination of two treatments and at least two therapies, with PTT as one of the included therapies. Finally, we summarized the benefits and drawbacks of various therapeutic options and state of the art CuS‐based PTT and provided future directions for such therapies.